Document:

exv10w1

Exhibit 10.1

REINSURANCE GROUP OF AMERICA, INCORPORATED

FLEXIBLE STOCK PLAN

STOCK APPRECIATION RIGHT AWARD AGREEMENT

     Reinsurance Group of America, Incorporated, a Missouri corporation (the “Company”), and
«FirstName» «LastName» (the “Awardee”) hereby agree as follows:

SECTION 1

GRANT OF STOCK APPRECIATION RIGHT

     Pursuant to the Reinsurance Group of America, Incorporated Flexible Stock Plan (“Plan”) and
pursuant to action of the Committee charged with the Plan’s administration, the Company has granted
to the Awardee, effective ___________ (“Effective Date”), subject to the terms, conditions and
limitations stated in this agreement (“Agreement”) and the Plan, a Stock Appreciation Right
(“SAR”), which is granted with respect to («No_of_Shares») shares of the Common Stock of the
Company (each a “SAR Share”).

SECTION 2

EXERCISE PRICE PER SAR SHARE

     The Exercise Price Per SAR Share shall be _______, which is the Fair Market Value of one Share
of Company Common Stock as of the Effective Date of this Agreement.

SECTION 3

EXERCISE OF SAR

     (a) Right to Exercise. This SAR is exercisable during its Term, but only to the
extent vested on the date of such exercise.

     (b) Terms of Exercise. Upon proper exercise of any vested portion of the SAR, the
Awardee or the individual or entity authorized to exercise such SAR as provided herein shall be
entitled to receive the excess of (i) the Fair Market Value of the specified number of SAR Shares
as of the date of exercise (which shall be determined by multiplying the number of SAR Shares being
exercised by the Fair Market Value of one Share on the date of exercise) over (ii) an amount equal
to the Exercise Price Per Share multiplied by the number of SAR Shares being exercised. Such
excess, if any, shall be paid in whole Shares, the number of which shall be determined using the
Fair Market Value of one Share as of the date of exercise, disregarding any fractional shares.
Such Shares shall be delivered to the Awardee or the individual or entity authorized to exercise
such SAR as provided herein as soon as practicable following exercise of the SAR, but in no event
later than 30 days following the date of exercise of the SAR.

     (c) Method of Exercise. The SAR may be exercised in whole or in part at any time or
from time to time by delivering to the Secretary or Chief Financial Officer of the Company or by
sending by certified mail, postage prepaid, to the Company to the attention of the Secretary a
written request designating the number of SAR Shares to be so exercised, signed by the Awardee or
other individual authorized pursuant to the terms of this Agreement to exercise the SAR. As
promptly as practicable after such exercise of the SAR, the Company shall issue the number of
Shares
determined pursuant to Section 3(b) above to the Awardee or the individual or entity authorized to
exercise such SAR as provided herein.

 

 

SECTION 4

CONDITIONS AND LIMITATIONS ON RIGHT TO EXERCISE SAR

     (a) Vesting. Subject to paragraph (b) of this Section and subject to Sections 6 and
7, this SAR shall vest in four (4) equal annual installments of 25% commencing December 31 of the
year of grant. The SAR must be exercised if at all no later than ten (10) years from the Effective
Date (the “Expiration Date”). The SAR may be exercised in full or in part pursuant to this vesting
schedule. Upon a partial exercise of this SAR, the number of SAR Shares available for future
exercise shall be reduced by the portion of the SAR so exercised.

	 	 	 	 	 
	 	 	Cumulative Percentage of	 
	Date	 	SAR Shares That Are Vested	 
	December 31, 2011
	 	 	25	%
	 
	 	 	 	 
	December 31, 2012
	 	 	50	%
	 
	 	 	 	 
	December 31, 2013
	 	 	75	%
	 
	 	 	 	 
	December 31, 2014
	 	 	100	%

     (b) Exercise if No Longer an Employee.

     (1) Termination. Except as provided in paragraphs (2) or (3) below, the SAR
may be exercised only by the Awardee while the Awardee is an Employee or within 30 days
following termination of the Awardee’s status as an Employee. For purposes of this
Agreement, “Employee” means:

     (i) an officer or employee of the Company or one of its subsidiaries as
defined in Section 424(f) of the Internal Revenue Code of 1986, as amended (“Code”),
or

     (ii) an officer or employee of the Company’s parent as defined in Section
424(e) of the Code, provided the Awardee is serving in such capacity at the request
of the Company and the Company’s Chief Executive Officer approves the Awardee’s
continued participation in the Plan.

Notwithstanding the foregoing, the Awardee may exercise the SAR following termination
only to the extent the SAR was vested and had not been exercised prior to termination and in
no event may the SAR be exercised after the Expiration Date.

An approved leave of absence shall not constitute a termination for purposes of this Section
so long as the Awardee’s right to re-employment is guaranteed either by statute, local law,
contract or pursuant to any Company policy. Where re-employment is not so guaranteed,
termination shall be deemed to occur on the first day after the last day of such approved
period of leave (but not after the Expiration Date).

2

 

     (2) Disability or Death. Notwithstanding the vesting schedule set forth in
Section 4(a) above, in the event of the Awardee’s Disability or death while serving as an
Employee and prior to the Expiration Date, the SAR shall become immediately 100% vested with
respect to the portion of the SAR not exercised prior to the date of Disability or death,
and the SAR may be exercised at any time within five (5) years following the earlier to
occur of death or Disability, but in no event later than the Expiration Date. Should this
Section 4(b)(2) become operative because the Awardee died while serving as an Employee, or
should the Awardee die after the Awardee’s Disability, then the SAR may be exercised by (i)
a legatee or legatees of the Awardee under the Awardee’s last will; (ii) the Awardee’s
personal representative(s) under the Awardee’s last will or, if the Awardee died without a
will, the executor of the Awardee’s probate estate; or (iii) the trustee(s) of the Awardee’s
revocable living trust or of a trust indenture of which Awardee is a grantor or a
beneficiary.

For purposes of this Agreement, “Disability” means a physical or mental condition of the
Awardee arising after the Effective Date, which in the opinion of a qualified doctor of
medicine chosen by the Company prevents the Awardee from continuing as an Employee.

     (3) Retirement. In the event of the Awardee’s Retirement prior to the
Expiration Date, the SAR shall continue to vest following such Retirement as provided in
Section 4(a) above and shall remain exercisable as if the Awardee had continued his or her
employment with the Company following such Retirement. In no event may any portion of this
SAR be exercised after the Expiration Date. Notwithstanding the vesting schedule set forth
in Section 4(a) above, in the event of the Awardee’s death following Retirement but prior to
the Expiration Date, the SAR shall become immediately 100% vested with respect to the
portion of the SAR not exercised prior to the Awardee’s death. The SAR may be exercised at
any time within five (5) years following the Awardee’s death (but in no event later than the
Expiration Date) by (i) a legatee or legatees of the Awardee under the Awardee’s last will;
(ii) the Awardee’s personal representative(s) under the Awardee’s last will or, if the
Awardee died without a will, the executor of the Awardee’s probate estate; or (iii) the
trustee(s) of the Awardee’s revocable living trust or of a trust indenture of which Awardee
is a grantor or a beneficiary.

For purposes of this Agreement, “Retirement” means termination of the Awardee’s status as an
Employee after the Awardee has attained a combination of age and years of service that
equals at least sixty-five (65); provided that, the maximum number of years of service
credited for purposes of this calculation shall be ten (10).

SECTION 5

DELIVERY OF SHARES

     The Company shall not be required to issue or deliver any certificates for SAR Shares upon the
exercise of this SAR prior to (a) the admission of such shares to listing on any stock exchange on
which the Company’s Common Stock may then be listed, (b) the completion of any registration and/or
qualification of such shares under any state or federal laws or rulings or regulations of any
governmental regulatory body, which the Company shall determine to be necessary or advisable, or
(c) if the Company so requests, the filing with the Company by the Awardee or the purchaser acting
pursuant to Section 4(b) of a representation in writing at the time of such exercise that it is his
or her present intention to acquire the shares being purchased for investment and not for resale or
distribution.

3

 

SECTION 6

CHANGE OF CONTROL

     Notwithstanding the vesting schedule set forth in Section 4(a), in the event of a Change of
Control (as defined in the Plan) prior to the Awardee’s termination, Retirement, Disability or
death (as described in Section 4(b)), the SAR shall become immediately 100% vested with respect to
the portion of the SAR not exercised prior to the Change of Control (but in no event may the
Awardee exercise any portion of the SAR after the Expiration Date).

SECTION 7

CANCELLATION

     Notwithstanding anything herein to the contrary, this Agreement shall be cancelled and the SAR
granted hereby shall be forfeited, without any further action by the Committee, as a result of the
Awardee’s Malfeasance. In the event of such cancellation, all rights of the Awardee hereunder
shall terminate, irrespective of whether the SAR is otherwise vested, and the shares reserved for
use hereunder shall be available for future grant in accordance with the Plan. “Malfeasance” means
(1) any conduct, act or omission that is contrary to the Awardee’s duties as an Employee or that is
inimical or in any way contrary to the best interests of the Company or any of its Affiliates, or
(2) employment of the Awardee by or association of the Awardee with an organization that competes
with the Company or any of its Affiliates.

SECTION 8

MISCELLANEOUS

     (a) Rights in Shares Prior to Issuance. Prior to issuance of certificates for shares
of Common Stock, neither the Awardee nor his or her legatees, personal representatives, or
distributees, shall be deemed to be a holder of any shares of Common Stock subject to this SAR.

     (b) Non-assignability. This SAR shall not be transferable by the Awardee otherwise
than by will or by the laws of descent and distribution; provided that, the Awardee may transfer
the SAR during his or her lifetime to a revocable living trust of which the Awardee is grantor, or
to another form of trust indenture of which Awardee is a grantor or a beneficiary. This SAR may be
exercised during the Awardee’s lifetime only by the Awardee; the Awardee’s guardian, power of
attorney, or legal representative; or the trustee of the Awardee’s revocable living trust or of a
trust indenture of which Awardee is a grantor or a beneficiary.

     (c) Designation of Beneficiaries. The Awardee may file with the Company a written
designation of a beneficiary or beneficiaries to exercise, in the event of the Awardee’s death, the
SAR granted hereunder, subject to all of the provisions of the SAR Award and these Terms and
Conditions. An Awardee may from time to time revoke or change any such designation of beneficiary
and any designation of beneficiary under the Plan shall be controlling over any other disposition,
testamentary or otherwise; provided, however, that if the Committee shall be in doubt as
to the right of any such beneficiary to exercise the SAR, the Committee may recognize only an
exercise by the personal representative of the estate of the Awardee, in which case the Company,
the Committee and the members thereof shall not be under any further liability to anyone.

4

 

     (d) Changes in Capital Structure. If there is any change in the Common Stock of the
Company by reason of any stock dividend, spin-off, split-up, spin-out, recapitalization, merger,
consolidation, reorganization, combination or exchange of shares, the number of SARs and the
number, kind and class of shares available for SARs and the exercise price thereof, as applicable,
shall be appropriately adjusted by the Committee. The issuance of Shares for consideration and the
issuance of Share rights shall not be considered a change in the Company’s capital structure. No
adjustment provided for in this Section shall require the issuance of any fractional shares.

     (e) Right to Continued Employment. Nothing in this Agreement shall confer on the
Awardee any right to continued employment or interfere with the right of an employer to terminate
the Awardee’s employment at any time.

     (f) Tax Withholding. Awardee must pay, or make arrangements acceptable to the Company
for the payment of any and all federal, state, and local tax withholding that in the opinion of the
Company is required by law. Unless Employee satisfies any such tax withholding obligation by paying
the amount in cash or by check, the Company will withhold Shares having a Fair Market Value on the
date of withholding equal to the tax withholding obligation.

SECTION 9

TERMS OF THE PLAN

     This SAR is subject to all of the terms of the Plan whether or not such terms are set forth in
this Agreement, and capitalized terms not specifically defined herein shall have the meanings
ascribed to them in the Plan.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of this ___ day of
________, 2011.

“Company”

Reinsurance Group of America, Incorporated

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	A. Greig Woodring 	 
	 	 	Title:  	President and Chief Executive Officer 	 
	 
	 	“Awardee”

 	 
	 	 	 
	 	 	 
	 	 	 
	 	
Name: «FirstName» «LastName»

 	 
	 	 	 
	 	 	 
	 	 	 
	 

5exv10w77

Exhibit 10.77

BAKER HUGHES INCORPORATED

Compensation Table for Named Executive Officers and Directors

Named Executive Officers:

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Base Salary
	 	 	Current	 	Effective
	 	 	Base Salary	 	April 20112
	Chad C. Deaton 1
	 	$	1,155,000	 	 	$	1,281,364	 
	Martin S. Craighead
	 	 	650,000	 	 	 	710,526	 
	Peter A. Ragauss
	 	 	650,000	 	 	 	680,526	 
	Alan R. Crain
	 	 	473,000	 	 	 	499,429	 
	John A. O’Donnell
	 	 	400,000	 	 	 	424,500	 

Non-Employee Directors3:

	 	 	 	 	 

	Annual Cash Retainer:
	 	$	75,000	 
	Audit/Ethics Committee Chairman Annual Retainer:
	 	$	20,000	 
	Other Committee Chairman Annual Retainer:
	 	$	15,000	 
	Audit/Ethics Committee Members Retainer:
	 	$	10,000	 
	Other Committee Members Retainer

(Excluding Executive Committee):
	 	$	5,000	 
	Lead Director
	 	$	15,000	 
	 
	 	 	 	 
	Annual Non-Retainer Equity (restricted stock awarded in January,
stock options awarded 50% in January and
 50% in July of each
year):
	 	$	200,000	 

 

			
	1	 	Mr. Deaton has an Amended and Restated Employment Agreement with Baker Hughes Incorporated,
filed as Exhibit 10.1 to Current Report on Form 8-K filed December 19, 2008.
	 
	2	 	In addition to their base salaries, these named executive officers, at the discretion of the
Board of Directors can receive equity compensation pursuant to the Baker Hughes Incorporated
2002 Director & Officer Long-Term Compensation Plan, filed as Exhibits 10.2 to Quarterly
Report on Form 10-Q for the quarter ended September 30, 2003; 10.3 to Quarterly Report on Form
10-Q for the quarter ended September 30, 2005; and 10.3 to Quarterly Report on Form 10-Q for
the quarter ended June 30, 2008. These named executive officers also are entitled to
participate in the Company’s Annual Incentive Compensation Plan, as amended and restated,
filed as Exhibits 10.15 and 10.16 to Annual Report of Baker Hughes Incorporated on Form 10-K
for the year ended December 31, 2007 and December 31, 2008,
respectively. In 2011, the Executive Perquisite Program will be
eliminated for the Named Executive Officers.
	 
	3	 	Non-employee directors are reimbursed for reasonable travel and related expenses.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]